Skip to content
Screener

Claritev Corporation CTEV Business Segments — Stock-based compensation, including cRSUs

Similar metrics at other companies

Stem logo
STEMReportable Segment — Compensation expense, excluding stock-based compensation
$10.27M-28.1%
Cytek Biosciences, Inc. logo
CTKBReportable Segment — Marketing (excluding stock-based compensation)
$3.36M+9.5%
Cytek Biosciences, Inc. logo
CTKBReportable Segment — Sales (excluding stock-based compensation)
$9.04M+15.4%
Trinet Group logo
TNETReportable Segment — Stock based compensation
$16M+23.1%
Cadence Design Systems logo
CDNSReportable Segment — Stock based compensation
$146.89M+24.1%
Summit Therapeutics logo
SMMTReportable Segment — Compensation related costs, excluding stock-based compensation
$26.43M+66.7%

Other financials

Income statement

See full
Revenue$257.5M+6.6%
Gross profit$189.8M+5.0%
Operating income$23.4M+41.2%
Net income-$59.2M+5.5%
EPS (diluted)-$3.49+8.4%

Balance sheet

See full
Cash & equivalents$27.7M-58.9%
Total debt$4.7B+1.0%
Total equity-$294.6M-638%
Total assets$4.8B-6.1%

Cash flow

See full
Operating cash flow$92.7M+51.3%
CapEx$38.1M+54.7%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$555.59M-45.3%
Enterprise value$5.2B-6.7%
P/S0.6×-0.5×

Profitability

See full
Gross margin73%-1.5pp
Operating margin-0.5%-0.3pp
Net margin-28.5%-10.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio0.0×

Where this comes from

Reported directly by Claritev Corporation in its filing.

Tagged under the XBRL concept ctev:CostDirectLaborShareBasedCompensation.

The source filing: Claritev Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001793229-26-000067
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenues$257,478$241,570$502,156$472,900
Cost of Services ("COS")
Personnel expenses excluding stock-based compensation52,57646,084103,93193,963
Stock-based compensation, including cRSUs3,1082,5185,4944,295
Access and bill review fees4,7966,71313,66612,221
Other cost of service expenses7,1875,50813,65610,780
Costs of services (exclusive of depreciation and amortization of intangible assets shown below)67,66760,823136,747121,259
General and Administrative ("G&A")

Item 1. Financial Statements

FAQ

What is Claritev Corporation's business segments — stock-based compensation, including crsus?
Claritev Corporation (CTEV) reported business segments — stock-based compensation, including crsus of $3.11M in Q2 2026.
How has Claritev Corporation's business segments — stock-based compensation, including crsus changed year-over-year?
Claritev Corporation's business segments — stock-based compensation, including crsus increased by 23.4% year-over-year, from $2.52M to $3.11M.
What is the long-term trend for Claritev Corporation's business segments — stock-based compensation, including crsus?
Over 2 years (2023 to 2025), Claritev Corporation's business segments — stock-based compensation, including crsus has grown at a 36.6% compound annual growth rate (CAGR), from $5.53M to $10.33M.
What does business segments — stock-based compensation, including crsus mean?
Captures the non-cash expense associated with equity-based awards granted to employees within the reportable segment. This metric is essential for understanding the total cost of talent acquisition and retention beyond cash payroll.

Ask your AI about Claritev Corporation's business segments — stock-based compensation, including crsus.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude